3 September 2026

Clinical research Pharmaceuticals

Autoimmune CAR-T trials paused after patient deaths

3 September 2026

Diabetes Pharmaceuticals

GLP-1 RAs: what longer-term use is revealing

3 September 2026

PBS Pharmaceuticals

PBS boost for lupus nephritis treatment

20 August 2026

PBS Pharmaceuticals

Butler vows to get GLP-1s on PBS, ‘one way or the other’

20 August 2026

Clinical research Pharmaceuticals Psoriatic Athritis

Sonelokimab clears phase 3 PsA hurdle

6 August 2026

Clinical research Pharmaceuticals

Novel nanobody prevails in myasthenia gravis trial

6 August 2026

Osteoporosis PBS Pharmaceuticals

PBS expands access to bone-building osteoporosis drug

6 August 2026

FDA Pharmaceuticals TGA

TGA reviews avacopan as new data submitted to FDA

23 July 2026

Guidelines Obesity Pharmaceuticals

ACP backs GLP-1s first for obesity

23 July 2026

PBAC Pharmaceuticals Rheumatology

PBAC agenda highlights for rheumatology

9 July 2026

PBS Pharmaceuticals Rheumatology

Another myasthenia gravis add-on given PBS listing

9 July 2026

ANCA-associated vasculitis FDA Pharmaceuticals

Avacopan trial retracted as regulators diverge

9 July 2026

ANCA-associated vasculitis Pharmaceuticals

CSL issues open letter as EU moves to revoke avacopan approval

9 July 2026

Interstitial Lung Disease Pharmaceuticals Rheumatoid Arthritis

Methotrexate comes out best in RA-ILD analysis

11 June 2026

Obesity Pharmaceuticals

How do people feel about using GLP-1 RAs?

28 May 2026

Diabetes Pharmaceuticals

TGA green light for first drug to slow type 1 diabetes